Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Manuel Sutton"'
Autor:
Zhenyu Jia, Michael B Lilly, James A Koziol, Xin Chen, Xiao-Qin Xia, Yipeng Wang, Douglas Skarecky, Manuel Sutton, Anne Sawyers, Herbert Ruckle, Philip M Carpenter, Jessica Wang-Rodriguez, Jun Jiang, Mingsen Deng, Cong Pan, Jian-Guo Zhu, Christine E McLaren, Michael J Gurley, Chung Lee, Michael McClelland, Thomas Ahlering, Michael W Kattan, Dan Mercola
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85010 (2014)
It is difficult to construct a control group for trials of adjuvant therapy (Rx) of prostate cancer after radical prostatectomy (RP) due to ethical issues and patient acceptance. We utilized 8 curve-fitting models to estimate the time to 60%, 65%,
Externí odkaz:
https://doaj.org/article/5af32894460a47e58eb7a65777f2bdf3
Autor:
Zhenyu Jia, Farah B. Rahmatpanah, Xin Chen, Waldemar Lernhardt, Yipeng Wang, Xiao-Qin Xia, Anne Sawyers, Manuel Sutton, Michael McClelland, Dan Mercola
Publikováno v:
PLoS ONE, Vol 7, Iss 9 (2012)
Externí odkaz:
https://doaj.org/article/e309b9f67dc34857ae79d41a9eb37064
Autor:
Zhenyu Jia, Farah B Rahmatpanah, Xin Chen, Waldemar Lernhardt, Yipeng Wang, Xiao-Qin Xia, Anne Sawyers, Manuel Sutton, Michael McClelland, Dan Mercola
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e41371 (2012)
Biomarkers are needed to address overtreatment that occurs for the majority of prostate cancer patients that would not die of the disease but receive radical treatment. A possible barrier to biomarker discovery may be the polyclonal/multifocal nature
Externí odkaz:
https://doaj.org/article/0990705d8f08431f9584763664402089
Autor:
Dan Mercola, Michael McClelland, Joseph Monforte, Thomas Beach, Waldemar Lernhardt, Manuel Sutton, Frank Meyskens, Anne Simoneau, Jessica Wang-Rodriguez, Philip Carpenter, Steve Goodison, James A. Koziol, Tolga Turan, Rebecca Pio, Qiang Xu, Xiao-Qin Xia, Farahnaz Rahmatpanah, Huazhen Yao, Anne Sawyers, Yipeng Wang, Zhenyu Jia
More than one million prostate biopsies are performed in the United States every year. A failure to find cancer is not definitive in a significant percentage of patients due to the presence of equivocal structures or continuing clinical suspicion. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9ff1055dce7298291f057a14eaa8ef1
https://doi.org/10.1158/0008-5472.c.6503012.v1
https://doi.org/10.1158/0008-5472.c.6503012.v1
Autor:
Dan Mercola, Michael McClelland, Joseph Monforte, Thomas Beach, Waldemar Lernhardt, Manuel Sutton, Frank Meyskens, Anne Simoneau, Jessica Wang-Rodriguez, Philip Carpenter, Steve Goodison, James A. Koziol, Tolga Turan, Rebecca Pio, Qiang Xu, Xiao-Qin Xia, Farahnaz Rahmatpanah, Huazhen Yao, Anne Sawyers, Yipeng Wang, Zhenyu Jia
Supplementary Tables 1-4, Figures 1-4 from Diagnosis of Prostate Cancer Using Differentially Expressed Genes in Stroma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c95c04bfb45af258b1b0d0a30ed423c
https://doi.org/10.1158/0008-5472.22390664
https://doi.org/10.1158/0008-5472.22390664
Autor:
Anne Sawyers, Jessica Wang-Rodriguez, Zhenyu Jia, Farahnaz Rahmatpanah, Dan Mercola, Manuel Sutton, Kathleen L. McGuire, Matthew A. Kinseth
Publikováno v:
International Journal of Cancer. 134:81-91
In prostate cancer, race/ethnicity is the highest risk factor after adjusting for age. African Americans have more aggressive tumors at every clinical stage of the disease, resulting in poorer prognosis and increased mortality. A major barrier to ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40f7f9c4912964bc29cf0a52cd1170b8
https://doi.org/10.1002/ijc.28326
https://doi.org/10.1002/ijc.28326
Autor:
Matthew A, Kinseth, Zhenyu, Jia, Farahnaz, Rahmatpanah, Anne, Sawyers, Manuel, Sutton, Jessica, Wang-Rodriguez, Dan, Mercola, Kathleen L, McGuire
Publikováno v:
International journal of cancer. 134(1)
In prostate cancer, race/ethnicity is the highest risk factor after adjusting for age. African Americans have more aggressive tumors at every clinical stage of the disease, resulting in poorer prognosis and increased mortality. A major barrier to ide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d4e9b3d97e01a11fe67453d1c1c64c5
https://pubmed.ncbi.nlm.nih.gov/23754304
https://pubmed.ncbi.nlm.nih.gov/23754304
Autor:
Manuel Sutton, Dan Mercola, Zhenyu Jia, Farah Rahmatpanah, Waldemar Lernhardt, Michael McClelland, Anne Sawyers, Xiao-Qin Xia, Yipeng Wang, Xin Chen
Publikováno v:
Jia, Zhenyu; Rahmatpanah, Farah B.; Chen, Xin; Lernhardt, Waldemar; Wang, Yipeng; Xia, Xiao-Qin; et al.(2012). Expression Changes in the Stroma of Prostate Cancer Predict Subsequent Relapse. PLoS ONE, 7(8). UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/8z83g4h6
PLoS ONE, Vol 7, Iss 8, p e41371 (2012)
Jia, Z; Rahmatpanah, FB; Chen, X; Lernhardt, W; Wang, Y; Xia, XQ; et al.(2012). Expression changes in the stroma of prostate cancer predict subsequent relapse.. PloS one, 7(8). doi: 10.1371/journal.pone.0041371. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/7631d2tx
PLoS ONE
PLoS ONE, Vol 7, Iss 8, p e41371 (2012)
Jia, Z; Rahmatpanah, FB; Chen, X; Lernhardt, W; Wang, Y; Xia, XQ; et al.(2012). Expression changes in the stroma of prostate cancer predict subsequent relapse.. PloS one, 7(8). doi: 10.1371/journal.pone.0041371. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/7631d2tx
PLoS ONE
Biomarkers are needed to address overtreatment that occurs for the majority of prostate cancer patients that would not die of the disease but receive radical treatment. A possible barrier to biomarker discovery may be the polyclonal/multifocal nature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0da4285b715b1646099c75da5437f011
http://www.escholarship.org/uc/item/8z83g4h6
http://www.escholarship.org/uc/item/8z83g4h6
Autor:
Farah Rahmatpanah, Xin Chen, Xiao-Qin Xia, Anne Sawyers, Waldemar Lernhardt, Michael McClelland, Zhenyu Jia, Dan Mercola, Manuel Sutton, Yipeng Wang
Publikováno v:
PLoS ONE, Vol 7, Iss 9 (2012)
PLoS ONE
PLoS ONE
The authors would like to include more information for one of the listed grants. The grant number for the grant from the Chao Family Comprehensive Cancer Center at University of California of Irvine (ZJ and DAM) is P30CA62203.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ca0ec7a6a11d41539a031d4691e273
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439507/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439507/?tool=EBI
Autor:
Frank L. Meyskens, James A. Koziol, Manuel Sutton, Xiao-Qin Xia, Joseph Monforte, Michael McClelland, Anne Sawyers, Thomas G. Beach, Tolga Turan, Huazhen Yao, Dan Mercola, Rebecca Pio, Yipeng Wang, Zhenyu Jia, Qiang Xu, Waldemar Lernhardt, Philip M. Carpenter, Jessica Wang-Rodriguez, Farahnaz Rahmatpanah, Anne R. Simoneau, Steve Goodison
More than one million prostate biopsies are performed in the United States every year. A failure to find cancer is not definitive in a significant percentage of patients due to the presence of equivocal structures or continuing clinical suspicion. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f2c9d855d9114a466dc5c91da6ac664
https://europepmc.org/articles/PMC3071046/
https://europepmc.org/articles/PMC3071046/